LATISSE® is the only FDA approved prescription treatment to grow eyelashes in people with hypotrichosis of the eyelashes (inadequate or not enough eyelashes). LATISSE® is believed to prolong the anagen (active growth) phase.1 The exact way it works is unknown. The onset of effect with LATISSE® solution is gradual. In the clinical trial, the majority of patients saw significant improvement by 2 months.1
The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE® solution may cause other less common side effects, which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
LATISSE® users are encouraged to call immediately if they develop a new eye condition (like an eye trauma or infection), experience a sudden decrease in vision, have eye surgery, or develop any eye reactions, particularly an infection and eyelid reactions.
LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower lid. If patients are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if they have a history of abnormal IOP, they should only use LATISSE® under the close supervision of their physician.